GoodRx Holdings (GDRX) EBT Margin (2019 - 2026)

GoodRx Holdings has disclosed EBT Margin across 8 years of filings, most recently posting 2.91% for Q1 2026.

• EBT Margin for Q1 2026 came in at 2.91%, down 531.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.78% (down 22.0% YoY), and the FY2025 annual result was 7.1%, up 312.0% from the prior year.
• EBT Margin came in at 2.91% for Q1 2026 at GoodRx Holdings, down from 7.29% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 9.64% in Q2 2025 to a low of 25.9% in Q3 2023.
• The 5-year median for EBT Margin is 3.11% (2025), against an average of 0.24%.
• Across the five-year window, EBT Margin plunged 1401 bps in 2023 and soared 3005 bps in 2024, its largest moves.
• GoodRx Holdings' EBT Margin stood at 2.58% in 2022, then plunged by 386 bps to 12.53% in 2023, then jumped by 146 bps to 5.75% in 2024, then grew by 27 bps to 7.29% in 2025, then plunged by 60 bps to 2.91% in 2026.
• The last three EBT Margin figures came in at 2.91% (Q1 2026), 7.29% (Q4 2025), and 3.11% (Q3 2025), per Business Quant data.